Cited by 334Per- and polyfluoroalkyl substances researchEffects and risks of endocrine disrupting chemicalsFluorine in Organic Chemistry

Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease

Open access
Rickard, Brittany P., Rizvi, Imran, Fenton, Suzanne E.·2022·Toxicology

Abstract

Per- and poly-fluoroalkyl substances (PFAS) are widespread environmental contaminants frequently detected in drinking water supplies worldwide that have been linked to a variety of adverse reproductive health outcomes in women. Compared to men, reproductive health effects in women are generally understudied while global trends in female reproduction rates are declining. Many factors may contribute to the observed decline in female reproduction, one of which is environmental contaminant exposure. PFAS have been used in home, food storage, personal care and industrial products for decades. Despite the phase-out of some legacy PFAS due to their environmental persistence and adverse health effects, alternative, short-chain and legacy PFAS mixtures will continue to pollute water and air and adversely influence women's health. Studies have shown that both long- and short-chain PFAS disrupt normal reproductive function in women through altering hormone secretion, menstrual cyclicity, and fertility. Here, we summarize the role of a variety of PFAS and PFAS mixtures in female reproductive tract dysfunction and disease. Since these chemicals may affect reproductive tissues directly or indirectly through endocrine disruption, the role of PFAS in breast, thyroid, and hypothalamic-pituitary-gonadal axis function are also discussed as the interplay between these tissues may be critical in understanding the long-term reproductive health effects of PFAS in women. A major research gap is the need for mechanism of action data - the targets for PFAS in the female reproductive and endocrine systems are not evident, but the effects are many. Given the global decline in female fecundity and the ability of PFAS to negatively impact female reproductive health, further studies are needed to examine effects on endocrine target tissues involved in the onset of reproductive disorders of women.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tox.2021.153031

Cites

237 of 237 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Studies that provided an estimate of half-life solely based on renal clearance were excluded, because PFAS are also excreted through other routes.

    “Additionally, we excluded all studies that provided an estimate of half-life solely based on renal clearance, since PFAS are also excreted through blood loss, maternal transfer to the foetus, breastfeeding, menstruation (Rickard et al., 2022), as well as through bile and faeces (Roberts et al., 2013; Chambers et al., 2021; Fletcher et al., 2022).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rickard, B. P., Rizvi, I., & Fenton, S. E.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • National Institute of Environmental Health Sciences (US)
Corresponding author
Fenton, Suzanne E.
Venue
Toxicology
Publisher
Elsevier BV
Published
2022-01
Volume
465
Pages
153031
ISSN
0300-483X (ISSN-L)
OpenAlex
W3214282621
Cited by
334
References
237
Citations by year
2026: 66 · 2025: 102 · 2024: 86 · 2023: 57 · 2022: 21 · 2021: 1
FWCI
3.02
Type
journal article
Language
en
Open access
Locations
  • Toxicology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Environmental Health Sciences (ZIA ES102785-11)
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Fluorine in Organic Chemistry
Keywords
per- and polyfluoroalkyl substances, PFAS, women's reproductive health, endocrine disruption, PFAS mixtures, short-chain PFAS, long-chain PFAS, menstrual cyclicity, female fertility, breast tissue, thyroid function, hypothalamic-pituitary-gonadal axis, drinking water contamination
MeSH terms
Endocrine System Diseases, Environmental Exposure, Environmental Pollutants, Female, Fertility, Humans, Hydrocarbons, Fluorinated, Infertility, Female, Menstrual Cycle, Pregnancy, Pregnancy Complications, Prognosis, Reproduction, Risk Factors, Risk Assessment, Endocrine Disruptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review